Wells Fargo’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21 | Hold |
2
| – | – | ﹤0.01% | 6319 |
|
|
2025
Q1 | $58 | Hold |
2
| – | – | ﹤0.01% | 5963 |
|
|
2024
Q4 | $192 | Hold |
2
| – | – | ﹤0.01% | 5862 |
|
|
2024
Q3 | $271 | Hold |
2
| – | – | ﹤0.01% | 5800 |
|
|
2024
Q2 | $307 | Hold |
2
| – | – | ﹤0.01% | 5797 |
|
|
2024
Q1 | $423 | Hold |
2
| – | – | ﹤0.01% | 5921 |
|
|
2023
Q4 | $1.36K | Hold |
2
| – | – | ﹤0.01% | 5713 |
|
|
2023
Q3 | $3.09K | Sell |
2
-52
| -96% | -$80.4K | ﹤0.01% | 5659 |
|
|
2023
Q2 | $245K | Buy |
54
+29
| +116% | +$132K | ﹤0.01% | 4225 |
|
|
2023
Q1 | $129K | Buy |
+25
| New | +$129K | ﹤0.01% | 4410 |
|
|
2022
Q4 | – | Hold |
0
| – | -$4K | – | 6235 |
|
|
2022
Q3 | – | Hold |
0
| – | -$2K | – | 5662 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | -$8K | – | 6093 |
|
|
2022
Q1 | $8K | Hold |
1
| – | – | ﹤0.01% | 6004 |
|
|
2021
Q4 | $10K | Hold |
1
| – | – | ﹤0.01% | 6010 |
|
|
2021
Q3 | $21K | Sell |
1
-1
| -50% | -$21K | ﹤0.01% | 5647 |
|
|
2021
Q2 | $38K | Buy |
+2
| New | +$38K | ﹤0.01% | 5347 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7043 |
|
|
2020
Q4 | – | Hold |
0
| – | -$2K | – | 6731 |
|
|
2020
Q3 | – | Hold |
0
| – | -$3K | – | 5802 |
|
|
2020
Q2 | – | Hold |
0
| – | -$2K | – | 5692 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5686 |
|
|
2015
Q4 | – | Hold |
0
| – | -$1K | – | 6098 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1K | – | 5776 |
|
|
2015
Q2 | – | Hold |
0
| – | -$1K | – | 5943 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 5820 |
|
|
2014
Q4 | – | Hold |
0
| – | -$1K | – | 5834 |
|
|
2014
Q3 | – | Hold |
0
| – | -$1K | – | 5858 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5790 |
|